Here, we interrogate this interaction and demonstrate that obesity-altered ASCs promote metastasis of TNBCs through leptin signaling which has implications for discovering novel therapeutic options in a malignancy that has an urgent need for novel targeted therapies. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.